Spandidos Publications style
Hong Q, Kuo E, Schultz L, Boackle RJ and Chang N: Conformationally altered hyaluronan restricts complement classical pathway activation by binding to C1q, C1r, C1s, C2, C5 and C9, and suppresses WOX1 expression in prostate DU145 cells. Int J Mol Med 19: 173-179, 2007.
APA
Hong, Q., Kuo, E., Schultz, L., Boackle, R.J., & Chang, N. (2007). Conformationally altered hyaluronan restricts complement classical pathway activation by binding to C1q, C1r, C1s, C2, C5 and C9, and suppresses WOX1 expression in prostate DU145 cells. International Journal of Molecular Medicine, 19, 173-179. https://doi.org/10.3892/ijmm.19.1.173
MLA
Hong, Q., Kuo, E., Schultz, L., Boackle, R. J., Chang, N."Conformationally altered hyaluronan restricts complement classical pathway activation by binding to C1q, C1r, C1s, C2, C5 and C9, and suppresses WOX1 expression in prostate DU145 cells". International Journal of Molecular Medicine 19.1 (2007): 173-179.
Chicago
Hong, Q., Kuo, E., Schultz, L., Boackle, R. J., Chang, N."Conformationally altered hyaluronan restricts complement classical pathway activation by binding to C1q, C1r, C1s, C2, C5 and C9, and suppresses WOX1 expression in prostate DU145 cells". International Journal of Molecular Medicine 19, no. 1 (2007): 173-179. https://doi.org/10.3892/ijmm.19.1.173
